RAREPLAY ANNOUNCES CLOUD-BASED SUPERCOMPUTERS INITIALLY TARGETING HIV & CANCER RESEARCH
LOS ANGELES (February 6, 2013) Thailand-based RarePlay.com announced today the launch of ElasticSwarm, technology that enables the creation of virtual supercomputers built from cloud-computing components.
Without a lot of fanfare, supercomputers are quietly transforming our lives.
Supercomputers design the cars we drive and many of the other products we use. Supercomputers forecast the weather, track storms and predict climate changes. Supercomputers manage our nations’ financial systems. Supercomputers ensure the safety of our air travel by planning and adjusting travel routes for jets.
And, more and more often, supercomputers help to design the medicines that treat and cure our illnesses like cancer, diabetes and numerous genetic disorders.
What are Supercomputers?
Supercomputers are actually very similar to the computers that most of us have on our desks. However, while most of us only have one computer on our desk, supercomputers are made up of thousands of those same computers linked together.
Each of the separate node computers in the supercomputer makes calculations from one perspective:
When all of those separate calculations are combined, complex problems are solved, solutions to difficult challenges are found, new approaches to treating illnesses are discovered.
Until now, supercomputers cost millions of dollars to build—typically from $5m-$30m and, then, millions of dollars more to operate. RarePlay’s ElasticSwarm technology allows supercomputers to be created for virtually $0 and substantially reduces the cost to operate them—by taking advantage of another new technology called “cloud computing”. That means that supercomputing power can be applied to a lot more of the problems that have perplexed mankind.
While supercomputing technology has potential applications across all aspects of society, RarePlay intends to initially focus on medical research. “It sounds like science fiction, but supercomputers have the potential to wipe out all pathogen-based diseases,” said RarePlay CEO, Ronald Knowlton.
“When we hear about diseases like Cancer, Malaria, Ebola, HIV, rabies, we frequently think they are an automatic ‘death sentence’. The reality is that every disease has a spectrum of patient outcomes: some patients succumb quickly, some patients linger for months or years and some amazing handful of people recover completely.”
“The genetic code of people who defy the odds for a particular disease hold clues about how to fight that disease. Their genetic code defines different proteins that give their bodies the ability to ward off that particular pathogen. We just need to locate that genetic code sequence to figure out how their bodies managed to fight that pathogen.”
Knowlton believes “Every pathogen-based illness should have its own supercomputer. Those machines would constantly examine the genetic code of the patients that defy the odds; looking for commonalities and differences in their genetic code.”
Knowlton has stated, “We’re not seeking intellectual property protection for the ElasticSwarm technology. We believe the application of vast, cheap computational power to all of mankind’s challenges will change everything we know about everything.”
“Trying to patent that or limit it in any way would be a disservice to humanity.”
An overview of the ElasticSwarm technology may be downloaded from: www.elasticSwarm.com/
RarePlay is leader in the application of machine learning (ML) to solve human challenges. The company is releasing a platform that enables the launching and harnessing of virtual supercomputers built from cloud computing components. The first targeted application of this supercomputing technology is for medical research to drive the elimination of pathogen-based illnesses including HIV, Cancer, and Malaria. RarePlay creates innovative digital solutions for clients around the world including Bayer Healthcare, Pfizer, Nestle, Estee Lauder, Seagate, ING and Skype.